Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.10780
Abstract: Key Points Question Are neutralizing antibodies against the Omicron variant of SARS-CoV-2 sufficiently induced after 2 to 3 doses of the BNT162b2 messenger RNA vaccine in recipients of different ages? Findings In this cohort study… read more here.
Keywords: omicron variant; neutralizing antibodies; antibodies omicron; doses bnt162b2 ... See more keywords
Neutralizing Antibodies Against the SARS-CoV-2 Omicron Variant (BA.1) 1 to 18 Weeks After the Second and Third Doses of the BNT162b2 mRNA Vaccine
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.12073
Abstract: This cohort study examines neutralizing antibodies against the SARS-CoV-2 Omicron variant (BA.1) after the second and third doses of the BNT162b2 mRNA vaccine among Danish adults. read more here.
Keywords: omicron variant; neutralizing antibodies; cov omicron; second third ... See more keywords
Cross‐neutralization of RBD mutant strains of SARS‐CoV‐2 by convalescent patient derived antibodies
Sign Up to like & getrecommendations! Published in 2021 at "Biotechnology Journal"
DOI: 10.1002/biot.202100207
Abstract: Abstract Background The emergence of COVID‐19 pandemic resulted in an urgent need for the development of therapeutic interventions. Of which, neutralizing antibodies play a crucial role in the prevention and resolution of viral infection. Methods… read more here.
Keywords: neutralization rbd; cross neutralization; neutralizing antibodies; sars cov ... See more keywords
A pan-genotype hepatitis C virus viral vector vaccine generates T-cells and neutralizing antibodies in mice.
Sign Up to like & getrecommendations! Published in 2022 at "Hepatology"
DOI: 10.1002/hep.32470
Abstract: BACKGROUND & AIMS A prophylactic vaccine targeting multiple HCV genotypes (gt) is urgently required to meet World Health Organization (WHO) elimination targets. Neutralizing antibodies (nAb), CD4+ and CD8+ T-cells are associated with spontaneous clearance of… read more here.
Keywords: viral vector; pan genotype; hcv; neutralizing antibodies ... See more keywords
A method comparison of three immunoassays for detection of neutralizing antibodies against SARS-CoV-2 receptor-binding domain in individuals with adenovirus type-5-vectored COVID-19 vaccination.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of clinical laboratory analysis"
DOI: 10.1002/jcla.24306
Abstract: OBJECTIVE Detecting neutralizing antibodies targeting receptor-binding domain (RBD) is important for the assessment of humoral protection and vaccine efficacy after vaccination. We compared the performance of three surrogate immunoassays for detection of neutralizing antibodies targeting… read more here.
Keywords: binding domain; comparison; vaccination; detection ... See more keywords
Dynamic observation of SARS‐CoV‐2 IgM, IgG, and neutralizing antibodies in the development of population immunity through COVID‐19 vaccination
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24325
Abstract: Currently, mass vaccine inoculation against coronavirus disease‐2019 (COVID‐19) has been being implemented globally. Rapid and the large‐scale detection of serum neutralizing antibodies (NAbs) laid a foundation for assessing the immune response against SARS‐CoV‐2 infection and… read more here.
Keywords: dynamic observation; igm igg; observation sars; neutralizing antibodies ... See more keywords
The path to find an HIV vaccine
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the International AIDS Society"
DOI: 10.1002/jia2.25749
Abstract: Since the discovery that a retrovirus, human immunodeficiency virus type one (HIV-1), causes the acquired immune deficiency syndrome (AIDS), more than 77 million people have become infected with HIV and 37 million have died over… read more here.
Keywords: hiv; antibody; efficacy; neutralizing antibodies ... See more keywords
Seroprevalence of coxsackievirus A21 neutralizing antibodies in Yamagata, Japan between 1976 and 2019; coxsackievirus A21 has rarely affected young children.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of medical virology"
DOI: 10.1002/jmv.27470
Abstract: Although coxsackievirus A21 (CV-A21) has been associated with acute respiratory infection (ARI) as well as poliomyelitis-like paralysis, reports of CV-A21 detection have been quite limited both globally and in Japan. CV-A21 strains were isolated from… read more here.
Keywords: neutralizing antibodies; young children; coxsackievirus a21; yamagata japan ... See more keywords
Neutralizing antibodies to SARS‐CoV‐2 variants of concern including Delta and Omicron in subjects receiving mRNA‐1273, BNT162b2, and Ad26.COV2.S vaccines
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28032
Abstract: SARS‐CoV‐2 vaccines have contributed to the control of COVID‐19 in some parts of the world. However, the constant emergence of variants of concern (VOCs) challenges the effectiveness of SARS‐CoV‐2 vaccines over time. In particular, Omicron… read more here.
Keywords: mrna 1273; neutralizing antibodies; bnt162b2; ad26 cov2 ... See more keywords
Vaccine‐induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28164
Abstract: Evidence about the long‐term persistence of the booster‐mediated immunity against Omicron is mandatory for pandemic management and deployment of vaccination strategies. A total of 155 healthcare professionals (104 COVID‐19 naive and 51 with a history… read more here.
Keywords: neutralizing antibodies; antibodies omicron; binding neutralizing; bnt162b2 booster ... See more keywords
Long‐term variations and potency of neutralizing antibodies against Omicron subvariants after CoronaVac‐inactivated booster: A 7‐month follow‐up study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28279
Abstract: The long‐term protective efficacy of neutralizing antibodies (Nabs) against Omicron subvariants after inactivated booster vaccines remains elusive. During the follow‐up study, 54 healthy volunteers aged 20–31 years received inactivated CoronaVac booster vaccinations and were monitored… read more here.
Keywords: long term; omicron subvariants; booster; neutralizing antibodies ... See more keywords